G protein-coupled receptors (GPCRs) constitute a large family of cell surface receptors, and play an important role in regulating cell survival and proliferation. They transduce environmental signals across the cytoplasm membrane through their ability to stimulate guanine nucleotide exchange by heterotrimeric G proteins, which induce multiple signaling cascades composed of scaffold/adaptor molecules and effector enzymes, leading to activation of many transcription factors including NF-kB. NF-kB is a family of transcription factors that play pivotal roles in regulating the expression of pro-inflammatory cytokines and pro-survival factors. Lysophosphatidic acid (LPA) is a potent bioactive lipid that elicits a wide variety of biological actions, particularly as an inducer of cell proliferation, migration, and survival, thereby, regulating wound healing, vascular remodeling, and tumor progression and metastasis. Binding LPA to its receptor, a GPCR family member, initiates multiple signaling pathways, leading to induction of pro-inflammatory and pro-angiogenic cytokines. It has also been shown that NF-kB is the key transcription factor mediating LPA- induced cytokine production. However, how GPCRs, such as LPA receptors, induce NF-kB activation remains largely unknown. In this application, we propose to investigate the molecular mechanism by which GPCRs induce NF-kB activation. Our preliminary studies indicate that NF-kB activation induced by several GPCR ligands, including LPA, endothelin-1, and serotonin, is dependent on two adaptor/scaffold molecules, CARMA3 and BcMO. Based on our preliminary studies, we hypothesize that CARMA3 and BcMO mediate a novel GPCR signal transduction pathway, leading to activation of NF-kB. In this application, we propose three specific aims to elucidate this novel signal transduction pathway. They are 1) to determine how the GPCR leads to activation of CARMA3;2) to determine the molecular mechanism by which CARMA3 activates downstream signaling cascades;3) to determine whether the CARMA3 is required for KSHV GPCR-induced NF-kB activation and malignancy. Elucidating this novel signal transduction pathway not only will reveal a general mechanism by which GPCRs induce NF-kB activation, but also provide therapeutic targets for modulating inflammation, wound healing, angiogenesis, and cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM079451-04
Application #
7858247
Study Section
Cellular Signaling and Dynamics Study Section (CSD)
Program Officer
Dunsmore, Sarah
Project Start
2007-08-03
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2012-05-31
Support Year
4
Fiscal Year
2010
Total Cost
$289,674
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Pan, D; Jiang, C; Ma, Z et al. (2016) MALT1 is required for EGFR-induced NF-?B activation and contributes to EGFR-driven lung cancer progression. Oncogene 35:919-28
Pan, Deng; Zhu, Yifan; Zhou, Zhicheng et al. (2016) The CBM Complex Underwrites NF-?B Activation to Promote HER2-Associated Tumor Malignancy. Mol Cancer Res 14:93-102
Blonska, Marzenna; Zhu, Yifan; Chuang, Hubert H et al. (2015) Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment. Blood 125:981-91
Jiang, Changying; Lin, Xin (2015) Analysis of epidermal growth factor-induced NF-?B signaling. Methods Mol Biol 1280:75-102
Pan, Deng; Lin, Xin (2013) Epithelial growth factor receptor-activated nuclear factor ?B signaling and its role in epithelial growth factor receptor-associated tumors. Cancer J 19:461-7
Kingeter, Lara M; Lin, Xin (2012) C-type lectin receptor-induced NF-?B activation in innate immune and inflammatory responses. Cell Mol Immunol 9:105-12
Jiang, Changying; Lin, Xin (2012) Regulation of NF-?B by the CARD proteins. Immunol Rev 246:141-53
Blonska, Marzenna; Lin, Xin (2011) NF-?B signaling pathways regulated by CARMA family of scaffold proteins. Cell Res 21:55-70
Jiang, Tang; Grabiner, Brian; Zhu, Yifan et al. (2011) CARMA3 is crucial for EGFR-Induced activation of NF-?B and tumor progression. Cancer Res 71:2183-92
Bi, Liangkuan; Gojestani, Sara; Wu, Weihui et al. (2010) CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans. J Biol Chem 285:25969-77

Showing the most recent 10 out of 13 publications